Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy"

Obesity Surgery

Volumn 21, Issue 12, 2011, Pages 1928-1936

  Appachi, Swathi ^a   Kelly, Karen R ^b   Schauer, Philip R ^b   Kirwan, John P ^b   Hazen, Stanley ^b   Gupta, Manjula ^b   Kashyap, Sangeeta R ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adipokines; Adiponectin; Bariatric surgery; Cholesterol; Gastric bypass; Leptin; Obesity; Tumor necrosis factor

Indexed keywords

ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK REDUCTION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TREATMENT OUTCOME;

ADIPOKINES; ADIPOSE TISSUE; BARIATRIC SURGERY; CARDIOVASCULAR DISEASES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84155169032     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0447-5     Document Type: Article

References (45)

1. HB Hubert M Feinleib PM McNamara, et al. 1983 Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 5 968 77 6219830 10.1161/01.CIR.67.5. 968 1:STN:280:DyaL3s7ls1WhtA%3D%3D (Pubitemid 13080473)
2. RH Eckel 1997 Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association Circulation 96 9 3248 50 9386201 1:STN:280:DyaK1c%2FksF2lug%3D%3D (Pubitemid 27500134)
3. P Poirier 2006 Obesity and Cardiovascular Disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation 113 6 898 918 16380542 10.1161/CIRCULATIONAHA.106.171016
4. H Bays N Abate M Chandalia 2005 Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia Future Cardiol 1 1 39 59 19804060 10.1517/14796678.1.1.39 1:CAS:528:DC%2BD2MXivVyitb0%3D
5. HE Bays B Laferrère J Dixon, et al. 2009 Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease? Int J Clin Pract 63 9 1285 300 19691612 10.1111/j.1742-1241.2009.02151.x 1:STN:280:DC%2BD1MrmsFymug%3D%3D
6. RS Ahima 2006 Adipose tissue as an endocrine organ Obesity 14 242S 9 17021375 10.1038/oby.2006.317 1:CAS:528:DC%2BD28XhtV2qu7jO
7. EE Kershaw JS Flier 2004 Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 6 2548 56 15181022 10.1210/jc.2004-0395 1:CAS:528: DC%2BD2cXmtlGqt7s%3D (Pubitemid 38766330)
8. M Blüher 2009 Adipose tissue dysfunction in obesity Exp Clin Endocrinol Diabetes 117 06 241 50 19358089 10.1055/s-0029-1192044
9. H Bays L Blonde R Rosenson 2006 Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Expert Rev Cardiovasc Ther 4 6 871 95 17173503 10.1586/14779072.4.6.871 (Pubitemid 46017525)
10. JL Miner 2004 The adipocyte as an endocrine cell J Anim Sci 82 3 935 41 15032452 1:CAS:528:DC%2BD2cXhvVCrsrc%3D (Pubitemid 38572360)
11. Y Fu 2005 Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation J Lipid Res 46 7 1369 79 15834118 10.1194/jlr.M400373-JLR200 1:CAS:528:DC%2BD2MXmtFKksL0%3D (Pubitemid 43109800)
12. G Frühbeck J Gómez-Ambrosi 2001 Rationale for the existence of additional adipostatic hormones FASEB J 15 11 1996 2006 11532980 10.1096/fj.00-0829hyp (Pubitemid 32848804)
13. A Shankar J Xiao 2010 Positive relationship between plasma leptin level and hypertension Hypertension 56 4 623 8 20713919 10.1161/HYPERTENSIONAHA.109. 148213 1:CAS:528:DC%2BC3cXhtFKls7jP
14. A Rodriguez A Fortuno J Gomez-Ambrosi, et al. 2006 The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism Endocrinology 148 1 324 31 17038553 10.1210/en.2006-0940
15. M Ruano V Silvestre R Castro, et al. 2005 Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis Obes Surg 15 5 670 6 15946459 10.1381/0960892053923734 1:STN:280:DC%2BD2MzgtFaktA%3D%3D (Pubitemid 40847958)
16. A Hammoud M Gibson SC Hunt, et al. 2009 Effect of roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men J Clin Endocrinol Metab 94 4 1329 32 19174499 10.1210/jc.2008-1598 1:CAS:528: DC%2BD1MXksFaiur4%3D
17. L Sjöström A Lindroos M Peltonen, et al. 2004 Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery N Engl J Med 351 26 2683 93 15616203 10.1056/NEJMoa035622 (Pubitemid 39665322)
18. AJ Scheen M Letiexhe M Rorive, et al. 2005 Bariatric surgery: 10-year results of the Swedish Obese Subjects Study Rev Méd Liège 60 2 121 5 15819376 1:STN:280:DC%2BD2M7os1Wnsg%3D%3D (Pubitemid 40396158)
19. HJ Sugerman LG Wolfe DA Sica, et al. 2003 Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss Ann Surg 237 6 751 8 12796570 (Pubitemid 38174509)
20. H Buchwald 2004 Bariatric Surgery: A systematic review and meta-analysis JAMA 292 14 1724 37 15479938 10.1001/jama.292.14.1724 1:CAS:528: DC%2BD2cXos1OjtLg%3D (Pubitemid 39346675)
21. AE Pontiroli F Frigè M Paganelli, et al. 2008 In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: Effect of weight loss through surgery Obes Surg 19 6 745 50 18629594 10.1007/s11695-008-9626-4
22. P Linscheid M Christ-Crain R Stoeckli, et al. 2008 Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss Diabetes Obes Metab 10 12 1266 70 18494809 1:CAS:528:DC%2BD1MXlvVaqtg%3D%3D
23. B Whitson D Leslie T Kellogg, et al. 2007 Adipokine response in diabetics and nondiabetics following the roux-en-Y gastric bypass: A preliminary study J Surg Res 142 2 295 300 17640666 10.1016/j.jss.2007.03.036 1:CAS:528: DC%2BD2sXhtVOgs7bN (Pubitemid 47418830)
24. P Lofgren 2005 Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state J Clin Endocrinol Metab 90 11 6207 13 16131581 10.1210/jc.2005-0596 (Pubitemid 41606545)
25. GH Ballantyne A Gumbs IM Modlin 2005 Changes in insulin resistance following bariatric surgery and the adipoinsular axis: Role of the adipocytokines, leptin, adiponectin and resistin Obes Surg 15 5 692 9 15946462 10.1381/0960892053923789 (Pubitemid 40847960)
26. SR Kashyap DL Diab AR Baker, et al. 2009 Triglyceride levels and not adipokine Concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort Obesity 17 9 1696 701 19360015 10.1038/oby.2009.89 1:CAS:528:DC%2BD1MXhtVKkurjM
27. F González NS Rote J Minium, et al. 2007 Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia Obesity 15 10 2436 44 17925469 10.1038/oby.2007.289 (Pubitemid 350034037)
28. E Hell KA Miller MK Moorehead, et al. 2000 Evaluation of health status and quality of life after bariatric surgery: Comparison of standard roux-en-Y gastric bypass, vertical banded gastroplasty and laparoscopic adjustable silicone gastric banding Obes Surg 10 3 214 9 10929151 10.1381/ 096089200321643485 1:STN:280:DC%2BD3cvotFOlsg%3D%3D
29. L Angrisani M Lorenzo V Borrelli 2007 Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial Surg Obes Relat Dis 3 2 127 32 17331805 10.1016/j.soard.2006. 12.005 (Pubitemid 46444696)
30. GS Cowan CK Buffington 1998 Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery World J Surg 22 9 987 92 9717426 10.1007/s002689900504 (Pubitemid 28374618)
31. MA Trakhtenbroit JG Leichman MF Algahim, et al. 2009 Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery Am J Med 122 5 435 42 19375553 10.1016/j.amjmed.2008.10.035 1:CAS:528:DC%2BD1MXkslGlt7w%3D
32. Y Matsuzawa 2006 Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease Nat Clin Pract Cardiovasc Med 3 1 35 42 16391616 10.1038/ncpcardio0380 1:CAS:528:DC%2BD28XntlWqsQ%3D%3D (Pubitemid 43078211)
33. H Ashrafian CW le Roux A Darzi, et al. 2008 Effects of bariatric surgery on cardiovascular function Circulation 118 20 2091 102 19001033 10.1161/CIRCULATIONAHA.107.721027
34. LF Van Gaal IL Mertens CE De Block 2006 Mechanisms linking obesity with cardiovascular disease Nature 444 7121 875 80 17167476 10.1038/nature05487 (Pubitemid 46028447)
35. S Han M Quon J Kim, et al. 2007 Adiponectin and cardiovascular disease response to therapeutic interventions J Am Coll Cardiol 49 5 531 8 17276175 10.1016/j.jacc.2006.08.061 1:CAS:528:DC%2BD2sXht1Oks7Y%3D (Pubitemid 46177440)
36. P Dandona 1998 Tumor necrosis factor-α in sera of obese patients: fall with weight loss J Clin Endocrinol Metab 83 8 2907 10 9709967 10.1210/jc.83.8.2907 1:CAS:528:DyaK1cXltlajsr8%3D (Pubitemid 28493796)
37. DR Cottam SG Mattar E Barinas-Mitchell, et al. 2004 The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effects of weight loss Obes Surg 14 5 589 600 15186624 10.1381/096089204323093345 (Pubitemid 38716577)
38. H Kopp 2003 Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients Arterioscler Thromb Vasc Biol 23 6 1042 7 12714437 10.1161/01.ATV.0000073313. 16135.21 1:CAS:528:DC%2BD3sXktlantrw%3D (Pubitemid 36713558)
39. LA Vazquez 2004 Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery J Clin Endocrinol Metab 90 1 316 22 15507518 10.1210/jc.2003-032059 (Pubitemid 40116674)
40. AS Greenberg MS Obin 2006 Obesity and the role of adipose tissue in inflammation and metabolism Am J Clin Nutr 83 2 461S 5 16470013 1:CAS:528:DC%2BD28Xhs1ehsrs%3D
41. AM Xydakis 2004 Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction J Clin Endocrinol Metab 89 6 2697 703 15181044 10.1210/jc.2003-031826 1:CAS:528:DC%2BD2cXmtlGqtbk%3D (Pubitemid 38766352)
42. G Slater 2004 Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery J Gastrointest Surg 8 1 48 55 14746835 10.1016/j.gassur.2003.09.020 (Pubitemid 38117277)
43. RD Bloomberg A Fleishman JE Nalle, et al. 2005 Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 15 2 145 54 15802055 10.1381/0960892053268264 (Pubitemid 40315996)
44. A Zittermann 2003 Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41 1 105 12 12570952 10.1016/S0735-1097(02)02624-4 1:CAS:528:DC%2BD3sXpsVKjsQ%3D%3D (Pubitemid 36044411)
45. A Zittermann 2007 Vitamin D in preventive medicine: are we ignoring the evidence? BJN 89 05 552 10.1079/BJN2003837